Announcements Trials
Browse Landscape

Phase

Phase 2 48Phase 3 35Phase 1 7Phase NA 6Phase 4 4Phase 2/3 4Phase 1/2 3Phase EARLY_PHASE1 1

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1Breast 1

Conditions

Endometrial Neoplasms 2Prostatic Neoplasms 1Neoplasms 1Inflammatory Breast Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Ductal, Breast 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Gonadotropin-Releasing Hormone × Clear all
NCT07319429 2026-03-13

FEMUS

Fudan University

Phase 2/3 Recruiting
260 enrolled
Gynecologic

Endometrial Neoplasms

NCT02221999 2023-08-29

SHPD002

RenJi Hospital

Phase 2/3 Active not recruiting
250 enrolled
Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT03463252 2021-09-13

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

West China Second University Hospital

Phase 2/3 Recruiting
224 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡